Dr. Tamer Khayal served as TransMedics' Chief Commercial Officer from January 2018 until February 2026, when he transitioned to Senior Vice President of International.
He previously served as the company's Chief Medical Officer and Vice President of Clinical Development from 2006 to 2017 and as Director of Clinical Development from 2001 to 2006.
Prior to joining TransMedics he served for six years as Director of Clinical Affairs for Zentiva Group, a.s., a pharmaceutical company, leading clinical research, regulatory filings and clinical sales training for its Middle East and Africa operations, and was earlier a practicing physician; he holds an M.D. from Cairo University School of Medicine.